Less common symptoms include headaches, a thumping heart (palpitations), altered taste, loss of appetite, pale appearance, sore mouth or tongue and ringing in the ears (tinnitus)
MeHarg 6d Report this comment Thats awesome
Important differences exist regarding the cardiovascular effects of the GLP-1 RAs and SGLT2i medications, and these effects seem complementary
The small-molecule GLP-1RA estate will have many more lifecycle-extension opportunities for the originator
Athletes should also be aware that USADA identifies BPC-157 as a prohibited experimental peptide under the World Anti-Doping Agencys S0 category for unapproved substances
Int J Obes 36(6):843854 Rubino DM et al (2022) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial